NIEPUBLICZNY ZAKŁAD OPIEKI ZDROWOTNEJ BIF-MED S.C. A. Wawiernia,M. Roykiewicz,R. Roykiewicz

At NIEPUBLICZNY ZAKŁAD OPIEKI ZDROWOTNEJ BIF-MED S.C. in Bytom, a major share of the clinical trial activity focuses on immune system diseases and musculoskeletal diseases, especially conditions where inflammation drives ongoing pain and disability. The studies are mainly designed to test new treatments and better understand how to reduce disease activity in common autoimmune and joint disorders.

• Rheumatoid arthritis and related inflammatory joint disease
• Psoriatic arthritis, including axial symptoms
• Axial spondyloarthritis and other spondyloarthritis conditions
• Evaluation of new therapies aimed at improving symptom control and functional outcomes

Much of this work supports the search for more effective options for people living with chronic autoimmune diseases and persistent rheumatic diseases.

Another important research area at the site is systemic lupus erythematosus, a complex autoimmune condition that can affect multiple organs and greatly vary in severity. These trials are focused on assessing whether emerging therapies can lower disease activity and improve day-to-day disease control.

• Systemic lupus erythematosus
• Measuring reductions in lupus disease activity
• Testing the safety and tolerability of new treatment approaches
• Exploring options for patients receiving standard background care

The research reflects a strong interest in advancing treatment for difficult-to-manage connective tissue diseases and broader immune system phenomena.

The site also contributes to trials in skin and connective tissue diseases, with particular attention to plaque psoriasis and inflammatory conditions linked to psoriatic disease. These studies aim to determine whether new therapies can improve visible skin symptoms and overall inflammatory control.

• Plaque psoriasis
• Psoriatic arthritis with skin and joint involvement
• Assessing improvements in skin clearance and disease control
• Testing novel anti-inflammatory treatment strategies

Research in this area helps expand options for people affected by chronic psoriatic disease and related inflammatory disorders.

Several trials at this health care site address musculoskeletal diseases and joint degeneration, including conditions that cause pain, stiffness, and reduced mobility. The studies are aimed at evaluating whether investigational treatments can improve function, ease symptoms, and support better quality of life.

• Knee osteoarthritis
• Joint pain and physical function
• Obesity with osteoarthritis-related symptoms
• Comparing new approaches for symptom relief and functional improvement

This line of research is especially relevant for common joint diseases where long-term comfort and mobility are central treatment goals.

The clinical trial portfolio also includes work in nutritional and metabolic diseases and behavior and behavior mechanisms. These studies are focused on conditions that influence weight or health-related habits, with an emphasis on testing practical interventions that may support better long-term outcomes.

• Obesity
• Support for stopping nicotine-containing electronic cigarette use
• Behavioral support combined with medication-based cessation strategies
• Evaluating whether new approaches can improve health-related behavior change

This research broadens the site’s scope beyond inflammatory disease, showing interest in both metabolic health and behavioral medicine.